NEW YORK, NY / ACCESSWIRE / February 14, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
FirstCash, Inc. (NASDAQ:FCFS)
This lawsuit is on behalf of all persons who purchased shares of FirstCash common stock between February 1, 2018 and November 12, 2021, both dates inclusive.
A class action has commenced on behalf of certain shareholders in FirstCash, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) FirstCash had made more than 3,600 loans to over 1,000 active-duty members of the military and their families at usurious interest rates above 36% – and often exceeding 200% – in violation of the Military Lending Act (“MLA”) and the Consent Order Cash America had entered into with the Consumer Financial Protection Bureau (the “Order”); (b) FirstCash had failed to implement the remedial measures imposed by the Order; (c) FirstCash’s financial results were, in substantial part, the product of the Company’s violations of the MLA and the Order; and (d) as a result of the foregoing, FirstCash was exposed to a material undisclosed risk of legal, reputational and financial harm if the Company’s violations of the MLA and the Order were ever publicly disclosed.
Shareholders may find more information at https://securitiesclasslaw.com/securities/firstcash-inc-loss-submission-form/?id=23697&from=1
Shattuck Labs, Inc. (NASDAQ:STTK)
This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering; and/or (2) between October 9, 2020 and November 9, 2021, inclusive.
A class action has commenced on behalf of certain shareholders in Shattuck Labs, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the collaboration agreement with Takeda was not solid; (2) Takeda and Shattuck would “mutually agree” to terminate the collaboration agreement in essentially one year; (3) as a result, Shattuck would cease to receive any future milestone, royalty, or other payments from Takeda; and (4) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/shattuck-labs-inc-loss-submission-form/?id=23697&from=1
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Investors Affected: May 28, 2021 – November 26, 2021
A class action has commenced on behalf of certain shareholders in Fennec Pharmaceuticals Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Fennec had not successfully remediated, and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK, a new compound developed to reduce the incidence of hearing loss in children undergoing chemotherapy; (ii) as a result, the Food and Drug Administration likely to approve the Resubmitted Pedmark New Drug Application (“NDA”); (iii) accordingly, the regulatory and commercial prospects of the Resubmitted Pedmark NDA were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/fennec-pharmaceuticals-inc-loss-submission-form-2/?id=23697&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
https://www.accesswire.com/688773/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-FCFS-STTK-and-FENC